These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29867953)

  • 21. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection.
    Pawlik A; Domanski L; Rozanski J; Florczak M; Dabrowska-Zamojcin E; Dutkiewicz G; Gawronska-Szklarz B
    Transplant Proc; 2005 Jun; 37(5):2041-3. PubMed ID: 15964333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
    Yamada K; Miwa T; Liu J; Nangaku M; Song WC
    J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of donor-dependent genetic factors on long-term renal graft function.
    Krajewska M; Kościelska-Kasprzak K; Weyde W; Drulis-Fajdasz D; Madziarska K; Mazanowska O; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):2978-80. PubMed ID: 19857655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes.
    Aydin Ozgur B; Coskunpinar E; Bilgic Gazioglu S; Yilmaz A; Musteri Oltulu Y; Cakmakoglu B; Deniz G; Gurol AO; Yilmaz MT
    Immunol Invest; 2021 Jul; 50(5):478-491. PubMed ID: 32611246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen-G-14-base-pair-insertion/deletion polymorphism and graft survival in kidney transplant recipients.
    Hou W; Huang Z; Ji Z; Zhou J
    Exp Clin Transplant; 2014 Apr; 12(2):89-94. PubMed ID: 24702138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
    Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
    Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Complement-Dependent Cytotoxicity by MicroRNAs miR-200b, miR-200c, and miR-217.
    Hillman Y; Mazkereth N; Farberov L; Shomron N; Fishelson Z
    J Immunol; 2016 Jun; 196(12):5156-65. PubMed ID: 27183614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade.
    Shao F; Gao Y; Wang W; He H; Xiao L; Geng X; Xia Y; Guo D; Fang J; He J; Lu Z
    Nat Cancer; 2022 Oct; 3(10):1192-1210. PubMed ID: 36271172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.
    Mishra N; Mohata M; Narang R; Lakshmy R; Hazarika A; Pandey RM; Das N; Luthra K
    Front Immunol; 2019; 10():2072. PubMed ID: 31555286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Cyclooxygenase-2 (COX-2) gene promoter-1195 and allograft inflammatory factor-1 (AIF-1) polymorphisms on allograft outcome in Hispanic kidney transplant recipients.
    Vu D; Tellez-Corrales E; Shah T; Hutchinson I; Min DI
    Hum Immunol; 2013 Oct; 74(10):1386-91. PubMed ID: 23777936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.
    Liu M; Yang YJ; Zheng H; Zhong XR; Wang Y; Wang Z; Wang YG; Wang YP
    Oncol Rep; 2014 Dec; 32(6):2619-27. PubMed ID: 25241923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates.
    Chen RH; Naficy S; Logan JS; Diamond LE; Adams DH
    Xenotransplantation; 1999 Aug; 6(3):194-200. PubMed ID: 10503786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy.
    Hoffmann S; Park J; Jacobson LM; Muehrer RJ; Lorentzen D; Kleiner D; Becker YT; Hullett DA; Mannon R; Kirk AD; Becker BN
    Kidney Int; 2004 Oct; 66(4):1686-93. PubMed ID: 15458467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus.
    Ejaz A; Steinmann E; Bánki Z; Anggakusuma ; Khalid S; Lengauer S; Wilhelm C; Zoller H; Schloegl A; Steinmann J; Grabski E; Kleines M; Pietschmann T; Stoiber H
    PLoS One; 2012; 7(9):e45770. PubMed ID: 23049856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
    Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
    Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
    Taylor CT; Johnson PM
    Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation.
    Hwang YH; Ro H; Choi I; Kim H; Oh KH; Hwang JI; Park MH; Kim S; Yang J; Ahn C
    Transplantation; 2009 Sep; 88(5):699-705. PubMed ID: 19741468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.